75 related articles for article (PubMed ID: 24995964)
21. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
22. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP
Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis.
Ramaswami R; Tagawa T; Mahesh G; Serquina A; Koparde V; Lurain K; Dremel S; Li X; Mungale A; Beran A; Ohler ZW; Bassel L; Warner A; Mangusan R; Widell A; Ekwede I; Krug LT; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Transl Med; 2023 Sep; 21(1):653. PubMed ID: 37740179
[TBL] [Abstract][Full Text] [Related]
24. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
25. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
Morales AE; Gumenick R; Genovese CM; Jang YY; Ouedraogo A; Ibáñez de Garayo M; Pannellini T; Patel S; Bott ME; Alvarez J; Mun SS; Totonchy J; Gautam A; Delgado de la Mora J; Chang S; Wirth D; Horenstein M; Dao T; Scheinberg DA; Rubinstein PG; Semeere A; Martin J; Godfrey CC; Moser CB; Matining RM; Campbell TB; Borok MZ; Krown SE; Cesarman E
PLoS Pathog; 2024 Jan; 20(1):e1011881. PubMed ID: 38190392
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
27. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
Brown EE; Fallin MD; Goedert JJ; Chen R; Whitby D; Foster CB; Lauria C; Alberg AJ; Messina A; Montella M; Rezza G; Vitale F; Chanock SJ;
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):633-7. PubMed ID: 15767342
[TBL] [Abstract][Full Text] [Related]
28. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
Li Y; Zhong C; Liu D; Yu W; Chen W; Wang Y; Shi S; Yuan Y
Cancer Res; 2018 Jan; 78(1):230-245. PubMed ID: 29066510
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus.
Lagos D; Vart RJ; Gratrix F; Westrop SJ; Emuss V; Wong PP; Robey R; Imami N; Bower M; Gotch F; Boshoff C
Cell Host Microbe; 2008 Nov; 4(5):470-83. PubMed ID: 18996347
[TBL] [Abstract][Full Text] [Related]
30. Mast Cell Activation and KSHV Infection in Kaposi Sarcoma.
Ayers LW; Barbachano-Guerrero A; McAllister SC; Ritchie JA; Asiago-Reddy E; Bartlett LC; Cesarman E; Wang D; Rochford R; Martin JN; King CA
Clin Cancer Res; 2018 Oct; 24(20):5085-5097. PubMed ID: 30084838
[No Abstract] [Full Text] [Related]
31. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells.
McAllister SC; Hansen SG; Ruhl RA; Raggo CM; DeFilippis VR; Greenspan D; Früh K; Moses AV
Blood; 2004 May; 103(9):3465-73. PubMed ID: 14726403
[TBL] [Abstract][Full Text] [Related]
32. Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.
Yoo J; Lee HN; Choi I; Choi D; Chung HK; Kim KE; Lee S; Aguilar B; Kang J; Park E; Lee YS; Maeng YS; Kim NY; Koh CJ; Hong YK
PLoS Pathog; 2012; 8(6):e1002770. PubMed ID: 22719258
[TBL] [Abstract][Full Text] [Related]
33. Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma.
Si MW; Jagirdar J; Zhang YJ; Gao SJ; Yeh IT
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):61-5. PubMed ID: 15722795
[TBL] [Abstract][Full Text] [Related]
34. Latent KSHV infection increases the vascular permeability of human endothelial cells.
Guilluy C; Zhang Z; Bhende PM; Sharek L; Wang L; Burridge K; Damania B
Blood; 2011 Nov; 118(19):5344-54. PubMed ID: 21881052
[TBL] [Abstract][Full Text] [Related]
35. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R; Kasonkanji E; Gumulira J; Gondwe Y; Dewey M; Pan Y; Peng A; Pluta LJ; Kudowa E; Nyasosela R; Tomoka T; Tweya H; Heller T; Gugsa S; Phiri S; Moore DT; Damania B; Painschab M; Hosseinipour MC; Dittmer DP
Int J Cancer; 2023 Dec; 153(12):2082-2092. PubMed ID: 37602960
[TBL] [Abstract][Full Text] [Related]
36. An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus.
McAllister SC; Hanson RL; Grissom KN; Botto S; Moses AV
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28872106
[TBL] [Abstract][Full Text] [Related]
37. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.
Hansen A; Henderson S; Lagos D; Nikitenko L; Coulter E; Roberts S; Gratrix F; Plaisance K; Renne R; Bower M; Kellam P; Boshoff C
Genes Dev; 2010 Jan; 24(2):195-205. PubMed ID: 20080955
[TBL] [Abstract][Full Text] [Related]
38. Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts.
Dai L; Qin Z; Defee M; Toole BP; Kirkwood KL; Parsons C
Cancer Lett; 2012 May; 318(2):214-20. PubMed ID: 22186301
[TBL] [Abstract][Full Text] [Related]
39. Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states.
Privatt SR; Braga CP; Johnson A; Lidenge SJ; Berry L; Ngowi JR; Ngalamika O; Chapple AG; Mwaiselage J; Wood C; West JT; Adamec J
Cancer Metab; 2023 Aug; 11(1):13. PubMed ID: 37653396
[TBL] [Abstract][Full Text] [Related]
40. AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.
Reid EG; Shimabukuro K; Moore P; Ambinder RF; Bui JD; Han S; Martínez-Maza O; Dittmer DP; Aboulafia D; Chiao EY; Maurer T; Baiocchi R; Mitsuyasu R; Wachsman W;
Clin Cancer Res; 2022 Jun; 28(12):2646-2656. PubMed ID: 35247913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
